UnitedHealthcare
Vitrakvi (larotrectinib)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Solid Tumor with NTRK Gene Fusion:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Solid Tumor with NTRK Gene Fusion:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Specialty Pharmacy is Required: Not Defined

  • Quantity Limit: limit maximum 10 ML PER 1 day(s)
  • Orally administered anticancer medication.